IntroductionMultimorbidity and polypharmacy are current challenges when caring for the older population. Both have led to an increase of potentially inappropriate medication (PIM), illustrating the need to assess patients' attitudes towards deprescribing. We aimed to assess the prevalence of PIM use and whether this was associated with patient factors and willingness to deprescribe.MethodWe analysed data from the LESS Study, a cross-sectional study on self-reported medication and on barriers and enablers towards the willingness to deprescribe (rPATD questionnaire). The survey was conducted among multimorbid (>= 3 chronic conditions) participants >= 70 years with polypharmacy (>= 5 long-term medications). A subset of the Beers 2019 criteria ...
BACKGROUND Polypharmacy is an increasing problem, leading to increased morbidity and mortality, esp...
IMPORTANCE Little is known about why older adults decline deprescribing recommendations, primaril...
Background From 20 to 65 % of older adults receiving polypharmacy take at least one potentially inap...
INTRODUCTION Multimorbidity and polypharmacy are current challenges when caring for the older pop...
IntroductionMultimorbidity and polypharmacy are current challenges when caring for the older populat...
BackgroundMultimorbidity and polypharmacy are very common in older adults in primary care. Ideally, ...
BACKGROUND Multimorbidity and polypharmacy are very common in older adults in primary care. Ideal...
INTRODUCTION To reduce inappropriate polypharmacy, deprescribing should be part of patients' regu...
Background: Multimorbidity and polypharmacy are very common in older adults in primary care. Ideally...
The high prevalence of polypharmacy and potentially inappropriate medications in the elderly makes t...
Background: While there is evidence that supervised withdrawal of inappropriate medications might be...
Abstract Background Few studies have evaluated the characteristics of elderly patients with polyphar...
BACKGROUND Polypharmacy is an increasing problem, leading to increased morbidity and mortality, e...
Background Deprescribing is a partnership between practitioners, patients and caregivers. External c...
Background Deprescribing has been recommended for managing polypharmacy but deprescribing preventive...
BACKGROUND Polypharmacy is an increasing problem, leading to increased morbidity and mortality, esp...
IMPORTANCE Little is known about why older adults decline deprescribing recommendations, primaril...
Background From 20 to 65 % of older adults receiving polypharmacy take at least one potentially inap...
INTRODUCTION Multimorbidity and polypharmacy are current challenges when caring for the older pop...
IntroductionMultimorbidity and polypharmacy are current challenges when caring for the older populat...
BackgroundMultimorbidity and polypharmacy are very common in older adults in primary care. Ideally, ...
BACKGROUND Multimorbidity and polypharmacy are very common in older adults in primary care. Ideal...
INTRODUCTION To reduce inappropriate polypharmacy, deprescribing should be part of patients' regu...
Background: Multimorbidity and polypharmacy are very common in older adults in primary care. Ideally...
The high prevalence of polypharmacy and potentially inappropriate medications in the elderly makes t...
Background: While there is evidence that supervised withdrawal of inappropriate medications might be...
Abstract Background Few studies have evaluated the characteristics of elderly patients with polyphar...
BACKGROUND Polypharmacy is an increasing problem, leading to increased morbidity and mortality, e...
Background Deprescribing is a partnership between practitioners, patients and caregivers. External c...
Background Deprescribing has been recommended for managing polypharmacy but deprescribing preventive...
BACKGROUND Polypharmacy is an increasing problem, leading to increased morbidity and mortality, esp...
IMPORTANCE Little is known about why older adults decline deprescribing recommendations, primaril...
Background From 20 to 65 % of older adults receiving polypharmacy take at least one potentially inap...